Evidence map›Paper›PMID 33914231›Full record

ReviewImmunologic research2021

Iodoprophylaxis and thyroid autoimmunity: an update.

Claudia Teti, Marta Panciroli, Elena Nazzari, Giampaola Pesce, Stefano Mariotti, Antonella Olivieri, Marcello Bagnasco

Open access · hybridAbstract readReview
In one paragraph

Review in Immunologic research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. The effect of sodium restriction on iodine prophylaxis: a review.Journal of endocrinological investigation · 2022
    Pooled it
  3. Article
  4. The role of nutrition on thyroid health and disease: myths and facts.Journal of endocrinological investigation · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Claudia Teti *Endocrinology and Diabetology Unit, ASL 1, Imperia, Italy.
Marta Panciroli *Department of Internal Medicine and Medical Specialties (DiMI), Genoa University, Viale Benedetto XV, 6 I-16132, Genova, Italy.
Elena NazzariEndocrinology and Diabetology Unit, ASL 2, Savona, Italy.
Giampaola PesceDepartment of Internal Medicine and Medical Specialties (DiMI), Genoa University, Viale Benedetto XV, 6 I-16132, Genova, Italy.
Stefano MariottiDepartment of Medicine and Public Health, University of Cagliari, Cagliari, Italy.
Antonella OlivieriDepartment of Cardiovascular and Endocrine-Metabolic Diseases and Aging, Italian National Institute of Health, Viale Regina Elena, 299, 00161, Roma, Italy.
Marcello BagnascoDepartment of Internal Medicine and Medical Specialties (DiMI), Genoa University, Viale Benedetto XV, 6 I-16132, Genova, Italy. bagnasco@unige.it.
University of Genoa · ITAzienda Sanitaria Locale N. 2 Savonese · ITAzienda Sanitaria Locale Roma 3 · ITIstituto Superiore di Sanità · ITUniversity of Cagliari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adequate iodine intake is necessary for normal thyroid function. Iodine deficiency is associated with serious complications, but also iodine excess can lead to thyroid dysfunction, and iodine supplementation aimed to prevent iodine deficiency disorders has been associated with development of thyroid autoimmunity. The epidemiology of thyroid diseases has undergone profound changes since the implementation of iodoprophylaxis, notably by means of iodine-enriched salt, specifically resulting in decreased prevalence of goiter and neonatal hypothyroidism, improved cognitive function development in infancy, and reduced incidence of more aggressive forms of thyroid cancer. The main question we address with this review is the clinical relevance of the possible effect on autoimmunity exerted by the use of iodine-enriched salt to correct iodine deficiency. In animal models, exogenous iodine is able to trigger or exacerbate thyroid autoimmunity, but it is still not clear whether the observed immunological changes are due to a direct effect of iodine on immune response, or whether they represent a secondary response to a toxic effect of iodine on thyroid tissue. Previous iodine status of a population seems to influence the functional thyroid response to increased iodine intake and possibly the development of thyroid autoimmunity. Moreover, the prevalence of thyroid antibodies, regarded as hallmark of autoimmune thyroid disease, varies between populations under the influence of genetic and environmental factors, and the presence of thyroid antibodies does not always coincide with the presence of thyroid disease or its future development. In addition, the incidence of autoimmune diseases shows a general increasing trend in the last decades. For all these reasons, available data are quite heterogeneous and difficult to analyze and compare. In conclusion, available data from long-term population surveys show that a higher than adequate population iodine intake due to a poorly controlled program of iodine prophylaxis could induce thyroid dysfunction, including thyroid autoimmunity mostly represented by euthyroid or subclinical hypothyroid autoimmune thyroiditis. Close monitoring iodine prophylaxis is therefore advised to ensure that effects of both iodine deficiency and iodine excess are avoided.

Indexed as

AnimalsAutoimmune DiseasesAutoimmunityHumansIodineSodium Chloride, DietaryThyroid DiseasesThyroid GlandIodineiodized saltSodium Chloride, DietaryGoiterIodineIodized saltThyroidThyroid autoimmunity

Identifiers

PMID33914231
PMCPMC8106604
OpenAlexW3158001498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.